Gynecologic Oncology | Interview with Ursula Matulonis, MD

published 2 months ago by Dr Neil Love

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr Matulonis on the following topics: Perspective on the use of immune checkpoint inhibitor (ICI) therapy for patients with ovarian cancer (00:00) Incorporation of pembrolizumab and pembrolizumab/lenvatinib into the management of endometrial cancer; optimal duration and schedule of pembrolizumab therapy (5:33) CME information and select publications

more episodes from Research To Practice | Oncology Videos